Venus Remedies secures final Rs. 11 crore payment from Cipla for AMR drug
The patented product, developed by Venus Medicine Research Centre (VMRC) for the treatment of multidrug-resistant (MDR) infections, was sold to Cipla in 2019
The patented product, developed by Venus Medicine Research Centre (VMRC) for the treatment of multidrug-resistant (MDR) infections, was sold to Cipla in 2019
This campaign is to raise awareness about the crucial role helmet usage plays in saving lives
Amrutanjan is also rolling out its new campaign, 'Har Dard Mitaye'
The conference stressed a multi-dimensional approach required to address Antimicrobial Resistance (AMR), focusing on the right approach and strengthening awareness
He will join in place of Anil Arora, current President- Formulations Operations who will be superannuating in November, 2024
He holds a Master’s in Management from the National University of Singapore
AMR poses a critical threat to global public health undermining decades of progress made in the field of modern medicine
e brings over 27+ years of rich pharmaceutical experience
The project funding will be done through a mix of internal accruals and debts.
Subscribe To Our Newsletter & Stay Updated